Literature DB >> 32936259

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.

Robert O Bonow1,2, Adrian F Hernandez3,4,5, Mintu Turakhia6,7,8,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32936259     DOI： 10.1001/jamacardio.2020.1782

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  10 in total

Review 1.  Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19.

Authors:  Ahmed S Ali; Mai A ASattar; Shahid Karim; Dina Kutbi; Hanin Aljohani; Duaa Bakhshwin; Mohammed Alsieni; Huda M Alkreathy
Journal:  Arab J Chem       Date:  2021-01-10       Impact factor: 5.165

Review 2.  Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Angelos Arfaras-Melainis; Andreas Tzoumas; Damianos G Kokkinidis; Maria Salgado Guerrero; Dimitrios Varrias; Xiaobo Xu; Luis Cerna; Ricardo Avendano; Cameron Kemal; Leonidas Palaiodimos; Robert T Faillace
Journal:  J Cardiovasc Dev Dis       Date:  2021-05-13

3.  Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.

Authors:  Ali S Omrani; Sameer A Pathan; Sarah A Thomas; Tim R E Harris; Peter V Coyle; Caroline E Thomas; Isma Qureshi; Zain A Bhutta; Naema Al Mawlawi; Reham Al Kahlout; Ashraf Elmalik; Aftab M Azad; Joanne Daghfal; Mulham Mustafa; Andrew Jeremijenko; Hussam Al Soub; Mohammed Abu Khattab; Muna Al Maslamani; Stephen H Thomas
Journal:  EClinicalMedicine       Date:  2020-11-20

4.  Of mice, microglia, and (wo)men: a case series and mechanistic investigation of hydroxychloroquine for complex regional pain syndrome.

Authors:  Elena S Haight; Emily M Johnson; Ian R Carroll; Vivianne L Tawfik
Journal:  Pain Rep       Date:  2020-08-25

5.  Remdesivir-Associated Significant Bradycardia: A Report of Three Cases.

Authors:  Maria Shirvani; Babak Sayad; Lida Shojaei; Azadeh Amini; Foroud Shahbazi
Journal:  J Tehran Heart Cent       Date:  2021-04

Review 6.  Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.

Authors:  Marco Infante; Camillo Ricordi; Andrea Fabbri
Journal:  J Diabetes       Date:  2020-06-11       Impact factor: 4.530

7.  Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events.

Authors:  Marta Cobos-Siles; Pablo Cubero-Morais; Irene Arroyo-Jiménez; María Rey-Hernández; Laura Hernández-Gómez; Derly Judith Vargas-Parra; María González-Fernández; Marina Cazorla-González; Miriam Gabella-Martín; Tomás Ruíz-Albi; José Angel Berezo-García; Jesús Fernando García-Cruces-Méndez; José Pablo Miramontes-González; Luis Corral-Gudino
Journal:  Intern Emerg Med       Date:  2020-09-10       Impact factor: 3.397

8.  Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.

Authors:  Marco Infante; Camillo Ricordi; Rodolfo Alejandro; Massimiliano Caprio; Andrea Fabbri
Journal:  Expert Rev Anti Infect Ther       Date:  2020-08-16       Impact factor: 5.091

9.  Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.

Authors:  Danyal Ibrahim; Latha Dulipsingh; Lisa Zapatka; Reginald Eadie; Rebecca Crowell; Kendra Williams; Dorothy B Wakefield; Lisa Cook; Jennifer Puff; Syed A Hussain
Journal:  Infect Dis Ther       Date:  2020-09-20

10.  Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.

Authors:  Marinella Lauriola; Arianna Pani; Giovanbattista Ippoliti; Andrea Mortara; Stefano Milighetti; Marjieh Mazen; Gianluca Perseghin; Daniele Pastori; Paolo Grosso; Francesco Scaglione
Journal:  Clin Transl Sci       Date:  2020-10-13       Impact factor: 4.689
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.